TELA Bio (TELA) Accumulated Expenses (2018 - 2026)

TELA Bio's Accumulated Expenses history runs 9 years deep, the most recent figure standing at $13.9 million for Q1 2026.

• On a quarterly basis, Accumulated Expenses rose 11.21% year-over-year to $13.9 million in Q1 2026; TTM through Mar 2026 was $13.9 million, a 11.21% increase from a year earlier, with the FY2025 full-year figure at $15.7 million, up 113.35% from the prior year.
• Accumulated Expenses eased to $13.9 million in Q1 2026 per TELA's latest filing, from $15.7 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $15.7 million in Q4 2025 and bottomed at $4.5 million in Q1 2023.
• The 5-year median for Accumulated Expenses is $9.2 million (2023), against an average of $9.3 million.
• Across the five-year window, Accumulated Expenses jumped 157.28% in 2022 and sank 49.2% in 2025, its largest moves.
• Year by year, Accumulated Expenses stood at $10.9 million in 2022, then fell by 15.21% to $9.2 million in 2023, then decreased by 20.32% to $7.3 million in 2024, then surged by 113.35% to $15.7 million in 2025, then fell by 11.02% to $13.9 million in 2026.
• Per Business Quant, the three latest TELA Accumulated Expenses figures stand at $13.9 million (Q1 2026), $15.7 million (Q4 2025), and $6.8 million (Q3 2025).